Viking Therapeutics plans offerings of common stock and convertible senior notes

Astellas doses first patient in Phase 3 lung cancer study

AstraZeneca's Trixeo Aerosphere approved in EU for asthma maintenance treatment

Ondine Biomedical deployssteriwave across five Southern Ontario hospitals

Ionis reports positive Phase 3 sefaxersen data in IgA nephropathy

X-Chem and Relay Therapeutics collaborate on Phase 3 milestone

BoomRay enters exclusive radioligand therapy asset global license agreement with Novartis

AstronauTx receives funding to explore sleep-based approaches for Parkinson's disease

AbbVie secures EU approval for RINVOQ in polyarticular juvenile idiopathic arthritis

Genentech reports positive Phase II results for enicepatide in type 2 diabetes

Pharming reports positive Phase II data for leniolisib in primary immunodeficiencies

Insmed's ARIKAYCE sNDA granted priority review by FDA

Precigen announces FDA platform technology designation for AdenoVerse

Enhertu recommended for EU approval in early HER2-positive breast cancer

PureTech receives FDA Fast Track designation for LYT-200 in HR-MDS